Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000343971

Medchemexpress LLC Rki-1447 dihydrochloride | 1782109-09-4 | 99.9% | 399.29 | 10 MG
SDP

Catalog No. 5000343971
Encompass_Preferred

RKI-1447 dihydrochloride is a potent and selective ROCK inhibitor, effectively suppressing colorectal carcinoma cell growth and promoting apoptosis. It functions by inhibiting ROCK1 (IC50 14.5 nM) and ROCK2 (IC50 6.2 nM), without affecting AKT, MEK, and S6 kinase phosphorylation. This compound has demonstrated significant anticancer activity in both in vitro and in vivo studies, including the inhibition of mammary tumor growth and antitumor effects in colorectal carcinoma.

  • Potent and selective ROCK inhibitor
  • Suppresses colorectal carcinoma cell growth
  • Promotes apoptosis in a dose-dependent manner
  • Inhibits phosphorylation of ROCK substrates MLC-2 and MYPT-1
  • Exhibits anticancer activity in colorectal carcinoma (CRC)
  • Inhibits mammary tumor growth in transgenic mice
  • Shows antitumor activity in CRC without physiological toxicity

Catalog No. 50-003-43971 Supplier Medchemexpress LLC Supplier No. HY11033910MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RKI-1447 dihydrochloride is a potent and selective ROCK inhibitor, effectively suppressing colorectal carcinoma cell growth and promoting apoptosis. It functions by inhibiting ROCK1 (IC50 14.5 nM) and ROCK2 (IC50 6.2 nM), without affecting AKT, MEK, and S6 kinase phosphorylation. This compound has demonstrated significant anticancer activity in both in vitro and in vivo studies, including the inhibition of mammary tumor growth and antitumor effects in colorectal carcinoma.

  • Potent and selective ROCK inhibitor
  • Suppresses colorectal carcinoma cell growth
  • Promotes apoptosis in a dose-dependent manner
  • Inhibits phosphorylation of ROCK substrates MLC-2 and MYPT-1
  • Exhibits anticancer activity in colorectal carcinoma (CRC)
  • Inhibits mammary tumor growth in transgenic mice
  • Shows antitumor activity in CRC without physiological toxicity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.